Numbers as they stand stack pretty like for like with CVV which is valued at A$100m. If you back A$75-100m out of our current MC I still think it makes Tomingley look cheap even considering recent miss steps (if that is how you want to phrase it).
To @Antipater_100 point this will end up a much longer life project than 17 years, once initial capex hurdle is gone then the requirement for additional material to make a profit will be a lot lower and this will go for decades.
On this basis an NPV kind of becomes a little redundant too. Numbers that are important are capex, payback period and annual EBITDA/FCF
AISC of A$600 on 150koz is cheap. That is basically $450m EBITDA/yr at spot prices.
Maybe they can consider non owner operated fleet etc and bring capex down and push opex up a little at the start to make the hurdle a little easier.
Grade for the 20Mtpa scenario is pretty low 0.26g/t Au and 0.15% Cu. First 5 years a bit higher at like 0.32g/t and 0.18% Cu
If we can find a 50Mt near surface pocket somewhere of even say 0.45g/t and 0.25% Cu (not asking for miracles) then that would make a huge difference in payback period and likelihood of project getting up.
At the end of the day this was always a bull market asset and this SS to me confirms that it is a pretty reasonable one.
Only takes a few things to go right and it gets a lot better
- Forums
- ASX - By Stock
- ALK
- Ann: Boda-Kaiser Scoping Study
Ann: Boda-Kaiser Scoping Study, page-18
-
- There are more pages in this discussion • 88 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALK (ASX) to my watchlist
(20min delay)
|
|||||
Last
47.0¢ |
Change
0.010(2.17%) |
Mkt cap ! $281.1M |
Open | High | Low | Value | Volume |
46.0¢ | 48.0¢ | 45.0¢ | $279.6K | 596.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 23618 | 47.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
47.5¢ | 59841 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 25163 | 0.470 |
6 | 21012 | 0.465 |
7 | 46265 | 0.460 |
9 | 79985 | 0.455 |
8 | 82834 | 0.450 |
Price($) | Vol. | No. |
---|---|---|
0.475 | 59841 | 8 |
0.480 | 88806 | 14 |
0.485 | 61851 | 8 |
0.490 | 44077 | 6 |
0.495 | 57659 | 2 |
Last trade - 11.51am 11/10/2024 (20 minute delay) ? |
Featured News
ALK (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online